NeoGenomics Announces Proposed Public Offering of Common Stock
FT. MYERS, FL / ACCESSWIRE / May 20, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
user
Evotec Jump-Starts Biologics with Acquisition of Just Biotherapeutics
EVOTEC'S OFFERING OF INTEGRATED SOLUTIONS EXTENDED TO BIOLOGICS ADDITION OF LONGSTANDING BIOLOGICS EXPERTISE BASED ON KEY TALENTS, INNOVATIVE ML (MACHINE...
ReShape Lifesciences Announces First Quarter 2019 Financial Results
SAN CLEMENTE, CA / ACCESSWIRE / May 20, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Biom’up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City
Biom'up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City...
ABMC Reports First Quarter 2019 Results
KINDERHOOK, NY / ACCESSWIRE / May 20, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results...
Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
DURHAM, NC / ACCESSWIRE / May 20, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed...
ReShape Lifesciences to Host First Quarter 2019 Conference Call on May 20, 2019
SAN CLEMENTE, CA / ACCESSWIRE / May 20, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Theralase Granted Notice of Acceptance for PhotoDynamic Compounds by Chinese Patent Office
TORONTO, ON / ACESSWIRE / May 20, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Biom’up provides 2019 guidance for HEMOBLAST(TM) Bellows global sales
Biom'up provides 2019 guidance for HEMOBLAST TM Bellows global sales Biom'up provides full-year 2019 guidance for global sales of HEMOBLAST...
10 Year Data Shows Long-Term Safety and Efficacy of GC Aesthetics Implants
DUBLIN, IRELAND / ACCESSWIRE / May 20, 2019 / GC Aesthetics (GCA) announced today that data from a European clinical...
Prevent Announces Management Changes and Termination of Services of CFO and VP Finance and Communications
CALGARY, AB / ACCESSWIRE / May 17, 2019 / Calgary, AB: Prevent Health Care International Corp. (the "Corporation") today announced...
Smile Solutions Dental Center to Open New Office in Fall 2019
MOUNT PROSPECT, IL / ACCESSWIRE / May 16, 2019 / Smile Solutions Dental Center is proud to announce that it...
Arcutis, Inc.’s ARQ-151 Development Program for Atopic Dermatitis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor Phase 1 Study in Atopic Dermatitis Completed Phase 2 Study Initiation Anticipated...
Sunshine Biopharma Announces that Essential 9TM is Now Available in the United States on Amazon.com
MONTREAL, QC / ACCESSWIRE / May 16, 2019 / Sunshine Biopharma, Inc. (OTC PINK: SBFM) today announced that its recently...
EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower
VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May...
GeneNews Announces Q1 2019 Results and Provides Progress Update
Company Launches National Marketing Campaign to Promote Telehealth Business Model, Processes First Patient-Directed Orders, In Discussions With International Distributor for...
Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): PDTI Reaches an Agreement in Principle to Joint Venture in a Seed to Sale CBD Enterprise
WINNIPEG, MB / ACCESSWIRE / May 15, 2019 / Preferred Dental Technologies Inc. ("Company") (CSE: PDTI, US OTC: PDTTF): PDTI...
Sapience Therapeutics to Present at the 2019 BIO International Convention
HARRISON, NY / ACCESSWIRE / May 16, 2019 / Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and...
CTD Announces Participation and Support for Upcoming Gathering of Patient-Support Organizations for Niemann-Pick Disease type C
ALACHUA, FL / ACCESSWIRE / May 16, 2019 / CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that...
Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device
52% Pantheris Revenue Growth in First 3 Quarters After Launch REDWOOD CITY, CA / ACCESSWIRE / May 16, 2019 /...